Newsroom
Sorted by: Latest
-
Science Corp. and Neurosoft Bioelectronics Announce Novel BCI Ecosystem Partnership
ALAMEDA, Calif. & GENEVA--(BUSINESS WIRE)--Science Corporation, the pioneering full-stack neural engineering company focused on restoring and extending life, and Neurosoft Bioelectronics, a neural data company utilizing ultra-soft interfaces to achieve full-cortical coverage powering a foundation AI model of the brain, have partnered to grant Neurosoft access to Science’s full stack of world-class clinical-grade neural recording tools, known as the Science BCI Ecosystem. Science Ecosystem partn...
-
Securities Fraud Investigation Into NuScale Power Corporation (SMR) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of NuScale Power Corporation (“NuScale” or the “Company”) (NYSE: SMR) investors concerning the Company’s possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON NUSCALE POWER CORPORATION (SMR), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Hap...
-
Community West Bancshares Announces Retirement of Board Member William S. Smittcamp Following 39 Years of Service
FRESNO, Calif.--(BUSINESS WIRE)--The Board of Directors of Community West Bancshares (“Company”) (NASDAQ: CWBC), the parent company of Community West Bank (“Bank”), announced today the retirement of Director William S. Smittcamp, effective March 31, 2026, following 39 years of distinguished service to the Company and the Bank. Mr. Smittcamp joined the Board during the Bank’s early years and has worked alongside most of the original founders and all four of the Bank’s Chief Executive Officers. O...
-
TrueFoundry Recognized as a Representative Vendor in Gartner Market Guide for AI Gateways
SAN FRANCISCO--(BUSINESS WIRE)--TrueFoundry, an enterprise AI infrastructure platform, today announced its recognition as a Representative Vendor in the 2025 Gartner Market Guide for AI Gateways. According to the report, by 2028, 70% of software engineering teams building multimodal applications will use AI gateways to improve reliability and optimize costs. Gartner defines an AI gateway as a technology or platform that “acts as an intermediary between applications and various AI services or mo...
-
Dalhousie’s Part-Time Architecture Faculty Join CUPE 3912
HALIFAX, NS--(BUSINESS WIRE)--Canadian Union of Public Employees (CUPE) Local 3912 is pleased to announce that part-time faculty in the Architecture Department at Dalhousie University (Dal) are officially members of our Local as of January 14, 2026, retroactive to November 2025. Architecture was one of only four departments at Dalhousie previously exempted from the part-time faculty collective agreement. With this change, only part-time faculty in Computer Science, Engineering, and Law remain o...
-
Medincell : La FDA américaine accepte le dossier de demande de mise sur le marché déposé par Teva pour l’Olanzapine LAI
PARSIPPANY, N.J. & TEL AVIV, Israël & PARIS--(BUSINESS WIRE)--Regulatory News: Teva Pharmaceuticals, filiale américaine de Teva Pharmaceutical Industries Ltd. (NYSE et TASE : TEVA), et Medincell (Euronext : MEDCL), annoncent que la Food and Drug Administration (FDA) américaine a accepté le dossier de demande d'autorisation de mise sur le marché américain (NDA) de l’injection sous-cutanée à libération prolongée d’olanzapine (TEV-‘749) pour le traitement de la schizophrénie chez l’adulte. L’Olanz...
-
Medincell: U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
PARSIPPANY, N.J. & TEL AVIV, Israel & PARIS--(BUSINESS WIRE)--Regulatory News: Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell (Euronext: MEDCL), announced today that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for olanzapine extended-release injectable suspension (TEV-'749) for the treatment of schizophrenia in adults. TEV-'749 is designed to improve real-world treatment adherence and...
-
AM Best Removes From Under Review With Developing Implications and Affirms Credit Ratings of CL Life and Annuity Insurance Company
OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has removed from under review with developing implications and affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb+” (Good) of CL Life and Annuity Insurance Company (CL Life) (Fort Worth, TX). The outlook assigned to these Credit Ratings (ratings) is stable. The ratings reflect CL Life’s balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance, neutral business...
-
KŌZĒ Stays Solidifies Its Dominance in the Region’s Luxury Rental Market with $10M+ Mont-Tremblant Estate
MONT-TREMBLANT, Québec--(BUSINESS WIRE)--KŌZĒ Stays, the leading vacation rental management company in the Mont-Tremblant and Laurentians region, announces the addition of a landmark private estate to its portfolio. The Exclusive Tremblant Cochrane Luxury Estate, valued at over $10,000,000, is now available to rent through KŌZĒ Stays. The property sets a new benchmark for the destination. Notably, one of the largest private residences currently available for rent in Mont-Tremblant, a category o...
-
CUPE Nova Scotia: “Long Term Care Is Dying, and Houston Is Letting It Happen”
HALIFAX, Nova Scotia--(BUSINESS WIRE)--Today, President of CUPE Nova Scotia Alan Linkletter sent a letter to Premier Houston calling on this conservative government to stop ignoring the hardworking long term care workers of this province and offer them a fair deal instead of lining the pockets of private companies. “Since Houston entered office, we have been overrun with examples of his government offering up millions of dollars in contracts to private companies instead of using that same money...